Comparison of therapeutic studies on regression of left ventricular hypertrophy

Advances in Experimental Medicine and Biology

Volumn 432, Issue , 1997, Pages 191-198

  Schmieder, Roland E ^a   Schlaich, Markus P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ALCOHOL CONSUMPTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG EFFICACY; DRUG POTENCY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTENSION; META ANALYSIS; OBESITY; PRIORITY JOURNAL; REMISSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM RESTRICTION; WEIGHT REDUCTION;

EID: 0031468914     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5385-4_21     Document Type: Conference Paper

References (19)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-66
2. Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens 1991; 9 (Suppl): S3-S9
3. Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB. Changes in left ventricular mass predict risk in essential hypertension [abstract], Ciculation 1990; 82 (suppl III): 20
4. Muiesan ML, Salvetti M, Rizzoni D, et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1996; 13: 1091-95
5. Jennings, G, Dart A, Meredith I, Korner P, Laufer E, Dewar E. Effects of exercise and other non-pharmacologic measures on blood pressure and cardiac hypertrophy. J Cardiovasc Pharmacol 1991; 17 (suppl 2): S70-S74
6. MacMahon SW, McDonald GJ, Bernstein L, et al. Comparison of weight reduction with metoprolol and treatment of hypertension in young overweight patients. Lancet 1986; 1: 1233-1236
7. MacMahon SW, Wilcken DEL, McDonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334-339
8. Liebson PR, Grandits TA, Dianzumba S, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698-706
9. Ferrara LA, DeSimone G, Pasanisi F, et al. Left Ventricular mass reduction during salt depletion in arterial hypertension. Hypertension 1984; 6: 755-759
10. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term non-pharmacological treatment with sodium restriction in mild to moderate hypertension. Circulation 1994; 89: 1023-1031
11. Neaton JD, Grimm RH, Prieas RJ, et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270: 713-724
12. Manolio TA, Levy D, Garrison RJ et al. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol 1991; 17: 717-721
13. Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy. Effects on lipids, blood pressure and left ventricular mass JAMA 1990; 263: 2766-2771
14. Senior R, Imbs JL, Bory M, et al. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. J Cardiovasc Pharmacol 1993; 22 (suppl 6): S106-S110
15. Gottdiener JS. Hypertensive heart disease in blacks. Cardiovasc Clin 1991; 21: 133-134
16. Sacks HS, Berrier J, Reitman D, Ancona-Berc VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450-455
17. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110
18. Cruickshank J, Lewis J, Moore EV, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive thearpy. J Hum Hypertens 1992; 6: 85-90
19. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996; 275: 1507-1513